ClinicalTrials.Veeva

Menu

Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor

H

Hospital Hietzing

Status

Completed

Conditions

Neovascular Age-related Macular Degeneration

Treatments

Device: OCT

Study type

Observational

Funder types

Other

Identifiers

NCT03679156
RPE characteristics

Details and patient eligibility

About

Purpose:

To assess retinal pigment epithelial (RPE) and retinal structural changes in eyes with neovascular age-related macular degeneration (AMD) treated with anti-vascular endothelial growth factor (anti-VEGF) during long-term follow-up and to evaluate morphological markers potentially influencing prognosis.

Methods:

18 patients (18 eyes) with neovascular AMD were recruited subsequent to completion the Avastin Versus Lucentis in Age Related Macular Degeneration (MANTA) study following a mean period of 84 months (range: 69-93 months). After receiving a loading dose of 3 intravitreal anti-VEGF injections subsequent to baseline of the MANTA study, patients were treated as-needed [pro re nata (PRN)]. Functional and morphological changes were assessed using spectral domain optical coherence tomography (SD-OCT).

Enrollment

18 patients

Sex

All

Ages

66 to 98 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Inclusion and exclusion criteria corresponded to the criteria of the MANTA study

Exclusion criteria

  • Inclusion and exclusion criteria corresponded to the criteria of the MANTA study

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems